These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29363875)

  • 1. The evolving mystery of why skeletal muscle is spared in seropositive neuromyelitis optica.
    Verkman AS; Yao X; Smith AJ
    J Cell Mol Med; 2018 Mar; 22(3):2039-2040. PubMed ID: 29363875
    [No Abstract]   [Full Text] [Related]  

  • 2. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.
    Cayrol R; Saikali P; Vincent T
    Ann N Y Acad Sci; 2009 Sep; 1173():478-86. PubMed ID: 19758189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of membrane complement regulators in neuromyelitis optica.
    Saadoun S; Papadopoulos MC
    Mult Scler; 2015 Nov; 21(13):1644-54. PubMed ID: 25698168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.
    Marignier R; Nicolle A; Watrin C; Touret M; Cavagna S; Varrin-Doyer M; Cavillon G; Rogemond V; Confavreux C; Honnorat J; Giraudon P
    Brain; 2010 Sep; 133(9):2578-91. PubMed ID: 20688809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aquaporin 4 expression and tissue susceptibility to neuromyelitis optica.
    Matiello M; Schaefer-Klein J; Sun D; Weinshenker BG
    JAMA Neurol; 2013 Sep; 70(9):1118-25. PubMed ID: 23857303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-aquaporin-4 antibodies in neuromyelitis optica: how to prove their pathogenetic relevance?
    Bradl M; Lassmann DH
    Int MS J; 2008 Sep; 15(3):75-8. PubMed ID: 18812056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.
    Bennett JL; Owens GP
    J Neuroophthalmol; 2017 Sep; 37(3):291-299. PubMed ID: 28410278
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G.
    Yao X; Verkman AS
    Acta Neuropathol Commun; 2017 Jul; 5(1):57. PubMed ID: 28750658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica.
    Tradtrantip L; Yao X; Su T; Smith AJ; Verkman AS
    Acta Neuropathol; 2017 Jul; 134(1):35-44. PubMed ID: 28567523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.
    Hinson SR; Roemer SF; Lucchinetti CF; Fryer JP; Kryzer TJ; Chamberlain JL; Howe CL; Pittock SJ; Lennon VA
    J Exp Med; 2008 Oct; 205(11):2473-81. PubMed ID: 18838545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of Neuromyelitis Optica: aquaporin 4 autoimmunity and astrocytopathy].
    Misu T; Fujihara K; Takahashi T; Takano R; Nishiyama S; Takai Y; Nakashima I; Sato S; Lassmann H; Itoyama Y
    Rinsho Shinkeigaku; 2010 Nov; 50(11):872. PubMed ID: 21921482
    [No Abstract]   [Full Text] [Related]  

  • 12. Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes.
    Wang Z; Guo W; Liu Y; Gong Y; Ding X; Shi K; Thome R; Zhang GX; Shi FD; Yan Y
    Brain Behav Immun; 2017 Oct; 65():173-182. PubMed ID: 28476558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aquaporin-4 autoantibodies cause asymptomatic aquaporin-4 loss and activate astrocytes in mouse.
    Chan KH; Zhang R; Kwan JS; Guo VY; Ho PW; Ho JW; Chu AC
    J Neuroimmunol; 2012 Apr; 245(1-2):32-8. PubMed ID: 22394609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
    Saikali P; Cayrol R; Vincent T
    Autoimmun Rev; 2009 Dec; 9(2):132-5. PubMed ID: 19389490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica and the evolving spectrum of water channel autoimmunity: a new direction.
    McKeon A; Pittock SJ
    Eur J Neurol; 2009 Apr; 16(4):433-5. PubMed ID: 19348617
    [No Abstract]   [Full Text] [Related]  

  • 16. Supramolecular aggregation of aquaporin-4 is different in muscle and brain: correlation with tissue susceptibility in neuromyelitis optica.
    Rosito S; Nicchia GP; Palazzo C; Lia A; Buccoliero C; Pisani F; Svelto M; Trojano M; Frigeri A
    J Cell Mol Med; 2018 Feb; 22(2):1236-1246. PubMed ID: 29055082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connexins in neuromyelitis optica: a link between astrocytopathy and demyelination.
    Richard C; Ruiz A; Cavagna S; Bigotte M; Vukusic S; Masaki K; Suenaga T; Kira JI; Giraudon P; Marignier R
    Brain; 2020 Sep; 143(9):2721-2732. PubMed ID: 32889550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the range of immunopathology in neuromyelitis optica spectrum disorder.
    Massey J; Buckland ME; Barnett Y; Sutton I
    BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27469383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
    Brück W; Popescu B; Lucchinetti CF; Markovic-Plese S; Gold R; Thal DR; Metz I
    Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica.
    Tradtrantip L; Duan T; Yeaman MR; Verkman AS
    J Neuroinflammation; 2019 Mar; 16(1):57. PubMed ID: 30851734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.